Advertisement

Index by author

July 01, 2012; Volume 342,Issue 1

  1. Mandt, Bruce H.

    1. Cocaine Dose and Self-Administration History, but Not Initial Cocaine Locomotor Responsiveness, Affects Sensitization to the Motivational Effects of Cocaine in Rats
      Bruce H. Mandt, Emily Gomez, Nickie L. Johnston, Nancy R. Zahniser and Richard M. Allen
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 214-221; DOI: https://doi.org/10.1124/jpet.112.194092

  2. Mark, Michael

    1. The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Attenuates Inflammation and Accelerates Epithelialization in Wounds of Diabetic ob/ob Mice
      Christoph Schürmann, Andreas Linke, Kerstin Engelmann-Pilger, Cornelia Steinmetz, Michael Mark, Josef Pfeilschifter, Thomas Klein and Stefan Frank
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 71-80; DOI: https://doi.org/10.1124/jpet.111.191098

  3. Martinez-chavez, Erick

    1. Pyroglutamyl Peptidase II Inhibition Enhances the Analeptic Effect of Thyrotropin-Releasing Hormone in the Rat Medial Septum
      Ivan Lazcano, Rosa Maria Uribe, Erick Martínez-Chávez, Miguel Angel Vargas, Magdalini Matziari, Patricia Joseph-Bravo and Jean-Louis Charli
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 222-231; DOI: https://doi.org/10.1124/jpet.112.192278

  4. Maruyama, Itaru

    1. Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey
      Itaru Maruyama, Satoshi Tatemichi, Yoshiaki Goi, Kazuyasu Maruyama, Yuji Hoyano, Yoshinobu Yamazaki and Hiroshi Kusama
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 163-168; DOI: https://doi.org/10.1124/jpet.112.191783

  5. Maruyama, Kazuyasu

    1. Effects of Ritobegron (KUC-7483), a Novel Selective β3-Adrenoceptor Agonist, on Bladder Function in Cynomolgus Monkey
      Itaru Maruyama, Satoshi Tatemichi, Yoshiaki Goi, Kazuyasu Maruyama, Yuji Hoyano, Yoshinobu Yamazaki and Hiroshi Kusama
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 163-168; DOI: https://doi.org/10.1124/jpet.112.191783

  6. Matziari, Magdalini

    1. Pyroglutamyl Peptidase II Inhibition Enhances the Analeptic Effect of Thyrotropin-Releasing Hormone in the Rat Medial Septum
      Ivan Lazcano, Rosa Maria Uribe, Erick Martínez-Chávez, Miguel Angel Vargas, Magdalini Matziari, Patricia Joseph-Bravo and Jean-Louis Charli
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 222-231; DOI: https://doi.org/10.1124/jpet.112.192278

  7. Megens, Anton

    1. Pharmacology of JNJ-37822681, a Specific and Fast-Dissociating D2 Antagonist for the Treatment of Schizophrenia
      Xavier Langlois, Anton Megens, Hilde Lavreysen, John Atack, Miroslav Cik, Paula te Riele, Luc Peeters, Ria Wouters, Jef Vermeire, Herman Hendrickx, Gregor Macdonald and Marcel De Bruyn
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 91-105; DOI: https://doi.org/10.1124/jpet.111.190702

  8. Mihic, S. John

    1. Positive Allosteric Modulators Differentially Affect Full versus Partial Agonist Activation of the Glycine Receptor
      Dean Kirson, Jelena Todorovic and S. John Mihic
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 61-70; DOI: https://doi.org/10.1124/jpet.112.191486

  9. Miller, Laurence L.

    1. Effects of Alterations in Cannabinoid Signaling, Alone and in Combination with Morphine, on Pain-Elicited and Pain-Suppressed Behavior in Mice
      Laurence L. Miller, Mitchell J. Picker, Michael D. Umberger, Karl T. Schmidt and Linda A. Dykstra
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 177-187; DOI: https://doi.org/10.1124/jpet.112.191478

  10. Mittapalli, Rajendar K.

    1. Impact of P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) on the Brain Distribution of a Novel BRAF Inhibitor: Vemurafenib (PLX4032)
      Rajendar K. Mittapalli, Shruthi Vaidhyanathan, Ramola Sane and William F. Elmquist
      Journal of Pharmacology and Experimental Therapeutics July 2012, 342 (1) 33-40; DOI: https://doi.org/10.1124/jpet.112.192195
« Previous (Pages : 5 6 7 8 9 10 11 12 13 14 ... 16) Next »
Back to top

In this issue

Advertisement